|
US5521297A
(en)
*
|
1993-06-04 |
1996-05-28 |
Salk Institute Biotechnology/Industrial Associates |
Nucleic acids encoding human metabotropic glutamate receptors
|
|
CA2200606A1
(en)
*
|
1995-07-26 |
1997-02-13 |
Nps Pharmaceuticals, Inc. |
Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases
|
|
US6221609B1
(en)
*
|
1996-07-03 |
2001-04-24 |
Eli Lilly And Company |
Isolate nucleic acid encoding human MGLUR8
|
|
IL138747A0
(en)
*
|
1998-04-03 |
2001-10-31 |
Nps Pharma Inc |
G-protein fusion receptors and chimeric gabab receptors
|
|
US7262280B1
(en)
|
1998-04-03 |
2007-08-28 |
Nps Pharmaceuticals, Inc. |
G-protein fusion receptors and constructs encoding same
|
|
AU772105B2
(en)
*
|
1998-08-18 |
2004-04-08 |
Johns Hopkins University School Of Medicine, The |
Homer interacting proteins
|
|
EP1662255A3
(en)
*
|
1998-08-18 |
2006-09-13 |
The Johns Hopkins University School Of Medicine |
Homer interacting proteins
|
|
EP2330192A1
(en)
*
|
1998-08-31 |
2011-06-08 |
The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin |
Polypeptides and polynucleotides from coagulase-negative staphylococci
|
|
US20030185754A1
(en)
*
|
2001-01-16 |
2003-10-02 |
Genset, S.A. |
Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
|
|
US20030166554A1
(en)
*
|
2001-01-16 |
2003-09-04 |
Genset, S.A. |
Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
|
|
US6620850B2
(en)
|
2001-09-19 |
2003-09-16 |
University Of Florida |
Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
|
|
US20050233321A1
(en)
*
|
2001-12-20 |
2005-10-20 |
Hess John W |
Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
|
|
WO2003059291A2
(en)
*
|
2002-01-10 |
2003-07-24 |
Osteotrophin Llc |
Treatment of bone disorders with skeletal anabolic drugs
|
|
AU2003298014A1
(en)
*
|
2002-12-04 |
2004-06-23 |
Diadexus, Inc. |
Compositions, splice variants and methods relating to colon specific genes and proteins
|
|
US20050186658A1
(en)
*
|
2003-10-17 |
2005-08-25 |
Nps Pharmaceuticals, Inc. |
Chimeric metabotropic glutamate receptors and uses thereof
|
|
WO2005073730A1
(en)
*
|
2004-01-31 |
2005-08-11 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 8 (mglur8)
|
|
ATE540048T1
(de)
*
|
2004-10-14 |
2012-01-15 |
Carnegie Inst Of Washington |
Neurotransmittersensoren und verfahren zu ihrer verwendung
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
US8889950B2
(en)
*
|
2006-07-28 |
2014-11-18 |
The George Washington University |
Repression of AtGLR3.2 increases plant biomass
|
|
US7424876B2
(en)
*
|
2006-10-06 |
2008-09-16 |
Ford Global Technologies, Llc |
Pushrod engine with multiple independent lash adjusters for each pushrod
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
DE602008004794D1
(de)
|
2007-09-14 |
2011-03-10 |
Addex Pharmaceuticals Sa |
1',3'-disubstituierte 4-phenyl-3,4,5,6-tetrahydro-2h,1'h-ä1,4'übipyridinyl-2'-one
|
|
US9217024B2
(en)
|
2007-12-18 |
2015-12-22 |
Acumen Pharmaceuticals, Inc. |
ADDL receptor polypeptides, polynucleotides and host cells for recombinant production
|
|
US20120093772A1
(en)
|
2008-05-20 |
2012-04-19 |
Alan Horsager |
Vectors for delivery of light sensitive proteins and methods of use
|
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
|
CN102232074B
(zh)
|
2008-11-28 |
2014-12-03 |
奥梅-杨森制药有限公司 |
作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
WO2010130422A1
(en)
|
2009-05-12 |
2010-11-18 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
AR076861A1
(es)
|
2009-05-12 |
2011-07-13 |
Addex Pharma Sa |
Derivados de 1,2,4-triazolo (4,3-a)piridina y su uso como moduladores alostericos positivos de los receptores de mglur2
|
|
US8993591B2
(en)
|
2010-11-08 |
2015-03-31 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
|
|
ES2552455T3
(es)
|
2010-11-08 |
2015-11-30 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
CA2814998C
(en)
|
2010-11-08 |
2019-10-29 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
PH12019500127B1
(en)
|
2014-01-21 |
2022-05-04 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
|
SMT201900545T1
(it)
|
2014-01-21 |
2019-11-13 |
Janssen Pharmaceutica Nv |
Combinazioni comprendenti modulatori allosterici positivi o agonisti ortosterici del recettore glutammatergico metabotropico sottotipo 2 e loro utilizzo
|
|
JP7026613B2
(ja)
|
2015-08-07 |
2022-02-28 |
イマジナブ・インコーポレーテッド |
標的分子に対する抗原結合コンストラクト
|
|
WO2018147960A1
(en)
|
2017-02-08 |
2018-08-16 |
Imaginab, Inc. |
Extension sequences for diabodies
|
|
US11344578B2
(en)
|
2017-04-19 |
2022-05-31 |
Board Of Regents, The University Of Texas System |
Immune cells expressing engineered antigen receptors
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|